Ascendis Health Limited provides earnings guidance for the full year ended June 2023. For the year, company expects earnings per share will be between 11.2 cents and 13.7 cents, representing a decrease of between 88.1% and 85.4% compared to the restated earnings per share from total operations of 93.6 cents reported for the prior corresponding period; and headline loss per share will be between 35.7 cents and 43.6 cents, representing an improvement of between 55.8% and 46.0% compared to the restated headline loss per share from total operations of 80.8 cents reported for the prior corresponding period.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.81 ZAR | 0.00% | +1.25% | +3.85% |
03-29 | Ascendis Health Seeks Acquisitions | CI |
03-28 | Ascendis Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.85% | 27.44M | |
+31.18% | 695B | |
+26.51% | 568B | |
-4.60% | 361B | |
+19.61% | 330B | |
+3.75% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+9.16% | 168B |
- Stock Market
- Equities
- ASC Stock
- News Ascendis Health Limited
- Ascendis Health Limited Provides Earnings Guidance for the Year Ended 30 June 2023